Abivax
ABVX
$8.80
Share price
-8.12%
Change (1 day)
-61.03%
Change (1 year)
Categories
Abivax (ABVX) - Cash on Hand
Cash on Hand as of December 2023 : A$0.47 Billion
According to Abivax's latest financial reports the company has A$0.47 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Abivax - Cash on Hand chart (from 2014 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | A$0.42 B | 896.86% |
| 2022-12-31 | A$42.48 M | -55.2% |
| 2021-12-31 | A$94.82 M | 102.3% |
| 2020-12-31 | A$46.87 M | 199.81% |
| 2019-12-31 | A$15.63 M | -25.96% |
| 2018-12-31 | A$21.11 M | -19.34% |
| 2017-12-31 | A$26.17 M | -21.96% |
| 2016-12-31 | A$33.54 M | -42.88% |
| 2015-12-31 | A$58.72 M | 1251.48% |
| 2014-12-31 | A$4.34 M | -15.16% |
| 2013-12-31 | A$5.12 M |